Literature DB >> 24867838

Menstrual migraine: treatment options.

L C Newman1, M S Yugrakh.   

Abstract

More than half of women with migraine note an association of headache attacks and their menstrual cycles. Headaches associated with menses are often more severe and disabling than headaches that occur other times of the month. First-line therapies include acute agents used for migraine in general; however, for many women, these therapies provide incomplete relief. In these situations, treatment options include short-term perimenstrual prevention employing nonsteroidal anti-inflammatory medications, triptans, or hormone-containing preparations. Should these options not suffice, or if menstrual cycles are irregular, continuous prevention using hormonal therapies or standard anti-migraine prophylaxis should be considered.

Entities:  

Mesh:

Year:  2014        PMID: 24867838     DOI: 10.1007/s10072-014-1743-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  Menstrual migraine: therapeutic approaches.

Authors:  E Anne Macgregor
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study.

Authors:  G Sances; E Martignoni; L Fioroni; F Blandini; F Facchinetti; G Nappi
Journal:  Headache       Date:  1990-11       Impact factor: 5.887

3.  Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.

Authors:  G Allais; G Acuto; X Cabarrocas; R Esbri; C Benedetto; G Bussone
Journal:  Neurol Sci       Date:  2006-05       Impact factor: 3.307

4.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  Naratriptan in the short-term prophylaxis of pure menstrual migraine.

Authors:  F Moschiano; G Allais; L Grazzi; S Usai; C Benedetto; D D'Amico; M Roncolato; G Bussone
Journal:  Neurol Sci       Date:  2005-05       Impact factor: 3.307

Review 6.  Management of menstrual migraine: a review of current abortive and prophylactic therapies.

Authors:  Elizabeth Sullivan; Cheryl Bushnell
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 7.  Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials.

Authors:  A Edelman; M F Gallo; M D Nichols; J T Jensen; K F Schulz; D A Grimes
Journal:  Hum Reprod       Date:  2006-03       Impact factor: 6.918

8.  Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.

Authors:  Elizabeth Loder; Stephen D Silberstein; Susan Abu-Shakra; Loretta Mueller; Timothy Smith
Journal:  Headache       Date:  2004-02       Impact factor: 5.887

Review 9.  Hormonal therapies for menstrual migraine.

Authors:  Anne H Calhoun; Susan Hutchinson
Journal:  Curr Pain Headache Rep       Date:  2009-10

10.  Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.

Authors:  Mario Guidotti; Michela Mauri; Caterina Barrilà; Francesca Guidotti; Carlo Belloni
Journal:  J Headache Pain       Date:  2007-10-23       Impact factor: 7.277

View more
  1 in total

1.  Acupuncture for menstruation-related migraine prophylaxis: A multicenter randomized controlled trial.

Authors:  Lu Liu; Claire-Shuiqing Zhang; Hui-Lin Liu; Fan He; Tian-Li Lyu; Lin Zeng; Luo-Peng Zhao; Mi-Na Wang; Zheng-Yang Qu; Li-Min Nie; Jia Guo; Xiao-Zhe Zhang; Yong-Hui Lu; Ke-Lun Wang; Bin Li; Xiang-Hong Jing; Lin-Peng Wang
Journal:  Front Neurosci       Date:  2022-08-26       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.